TipRanks
Advertisement
Advertisement
Abivax price target lowered to $151 from $155 at Truist
PremiumThe FlyAbivax price target lowered to $151 from $155 at Truist
9d ago
Abivax bolsters leadership and balance sheet as obefazimod nears commercialization
Premium
Company Announcements
Abivax bolsters leadership and balance sheet as obefazimod nears commercialization
10d ago
Abivax appoints Chris Rabbat as Chief Medical Officer
Premium
The Fly
Abivax appoints Chris Rabbat as Chief Medical Officer
10d ago
Abivax Updates Share Capital and Voting Rights as of July 31, 2026
PremiumCompany AnnouncementsAbivax Updates Share Capital and Voting Rights as of July 31, 2026
2M ago
Abivax announces positive pre-NDA interaction with FDA for obefazimod in UC
Premium
The Fly
Abivax announces positive pre-NDA interaction with FDA for obefazimod in UC
2M ago
Abivax Gains FDA Alignment on Obefazimod NDA Plan for Ulcerative Colitis
Premium
Company Announcements
Abivax Gains FDA Alignment on Obefazimod NDA Plan for Ulcerative Colitis
2M ago
PremiumCompany AnnouncementsAbivax Raises $920 Million in U.S. ADS Offering, Extending Cash Runway to 2029
3M ago
Abivax price target raised to $155 from $135 at Truist
Premium
The Fly
Abivax price target raised to $155 from $135 at Truist
3M ago
Abivax 6.4M share Spot Secondary priced at $125.00
Premium
The Fly
Abivax 6.4M share Spot Secondary priced at $125.00
3M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―